Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Amr Hanbali | King Faisal Specialist Hospital & Research Center | Saudi Arabia

Dr. Amr AlHanbali is a dual-certified Hematology and Oncology consultant with over 18 years of experience in malignant and benign hematological conditions. Based at King Faisal Specialist Hospital & Research Center in Riyadh, Saudi Arabia, he specializes in hematologic malignancies and stem cell transplantation. Dr. AlHanbali previously served as a senior staff physician and Associate Fellowship Program Director at Henry Ford Health System in Detroit, Michigan. Recognized for his academic involvement, he holds teaching appointments at Wayne State University and Alfaisal University. Known for his dedication to clinical mentorship, he has trained numerous medical students, residents, and fellows. He is actively involved in research and is a member of several prestigious medical organizations including the American Society of Hematology and American Society of Clinical Oncology. With expertise ranging from bone marrow procedures to managing complex hematologic disorders, Dr. AlHanbali is a respected leader in the field of hematology and stem cell transplantation.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Research Contribution

    • Over 17 peer-reviewed publications, including impactful case reports, national guidelines, and original research in hematology, oncology, and stem cell transplantation.

    • Active contributor to national guidelines on multiple myeloma, reflecting leadership in shaping national healthcare standards in KSA.

  2. Dual Academic and Clinical Roles

    • Combines academic excellence (as faculty at Wayne State University and Alfaisal University) with hands-on clinical expertise at a premier institution (King Faisal Specialist Hospital & Research Center).

  3. Innovative Focus in Hematology and Transplantation

    • Research into underexplored areas such as hepatitis B reactivation post-rituximab, genetic donor match outcomes, and therapies for AL amyloidosis.

  4. International Exposure and Leadership

    • Experience across the U.S. and Saudi Arabia, influencing programs in both systems.

    • Played a key role in training and selecting future hematology-oncology fellows in the U.S.

  5. Mentorship and Capacity Building

    • Mentored numerous trainees, enhancing research culture among younger clinicians.

Areas for Improvement:

  1. Higher Impact Publications Needed

    • While the volume and variety of research are commendable, more publications in top-tier journals (NEJM, Lancet, Blood, JCO) could boost citation impact and visibility.

  2. Research Grants and Collaborative Trials

    • Pursuing multicenter studies, international collaborations, or industry-sponsored clinical trials would further elevate his profile and expand research funding sources.

  3. Technological Innovation/Patents

    • Exploring biotech innovation, AI in diagnostics, or cellular therapy patents could position him among the top medical innovators.

Education:

Dr. Amr AlHanbali completed his Bachelor of Medicine and Surgery from the University of Jordan in 1999. He pursued medical training in the United States, starting with an internal medicine residency (2001–2004) at Henry Ford Health System, Detroit. He continued his specialization with a fellowship in Hematology and Oncology (2004–2007) at the same institution. During his training, he also undertook elective rotations in Pediatric Cardiology and Gastroenterology at the University of Texas Medical Branch, Galveston, further enriching his academic exposure. He is certified by the American Board of Internal Medicine in Internal Medicine (2004), Hematology (2007), and Oncology (2007). Dr. AlHanbali holds academic titles as a Clinical Assistant Professor at Wayne State University, Detroit, and Adjunct Associate Professor at Alfaisal University, Riyadh. His educational background reflects a strong foundation in internal medicine, with a deep focus on hematology and oncology, further supported by teaching and research excellence.

Experience:

Dr. AlHanbali’s clinical career spans over 18 years, currently serving as Hematology and Stem Cell Transplant Consultant at King Faisal Specialist Hospital & Research Center in Riyadh since 2013. Prior to this, he held multiple leadership roles at Henry Ford Health System, Detroit, including Senior Staff Physician and Associate Fellowship Program Director (2007–2013). His medical expertise covers the diagnosis and treatment of a wide range of hematologic malignancies such as leukemia, lymphoma, multiple myeloma, and myeloproliferative disorders. Dr. AlHanbali also has extensive experience in stem cell transplantation, intrathecal chemotherapy, and bone marrow biopsy. He has been instrumental in resident selection and curriculum development for fellowship programs in hematology and oncology. His work bridges clinical excellence with academic mentorship, guiding numerous trainees and junior physicians. In addition to patient care, he is involved in clinical guideline development and research, particularly in the field of multiple myeloma and transplant outcomes.

Research Focus:

Dr. Amr AlHanbali’s research is centered on hematologic malignancies, particularly multiple myeloma, lymphoma, leukemia, and stem cell transplantation. His work explores novel therapeutic approaches, transplant outcomes, disease progression, and treatment-related complications. He has contributed significantly to research on hepatitis B reactivation, chemotherapy-induced toxicities, and the protective role of comorbidities like diabetes in cancer metastasis. As an active member of the Saudi Myeloma Working Group, he has co-authored national guidelines for both newly diagnosed and relapsed/refractory multiple myeloma. His studies also examine health disparities in cancer care, including outcomes among African American populations and the impact of familial genetics in donor matches. With over a dozen peer-reviewed publications and case reports in high-impact journals, Dr. AlHanbali continues to push forward understanding in clinical hematology and oncology. He combines bedside insights with academic rigor to shape evidence-based practice and improve treatment outcomes in cancer and transplant medicine.

Publications Top Notes:

  1.  Mediastinal Hematoma With SVC Syndrome From A Central Venous Catheter Insertion – CHEST, 2003

  2.  Diabetes Has Protective Effect Against Metastasis in Non-Small Cell Lung Cancer – Arch Intern Med, 2007

  3.  Delayed Hepatitis B Viral Replication Post-Rituximab & Fludarabine in Waldenstrom Macroglobulinemia – Am J Hematol, 2007

  4.  Acute Pancreatitis Induced by Adult Precursor B-cell ALL – South Med J, 2007

  5.  Hypersensitivity Reaction of Mylotarg with Platelet Transfusion – Am J Health Syst Pharm, 2007

  6.  Incidence of Hepatitis B Reactivation after Rituximab Therapy – Am J Hematol, 2009

  7. Outcomes After Auto-SCT in African Americans with Multiple Myeloma – Bone Marrow Transplant, 2009

  8.  HER-2 Status May Change in Recurrent Breast Cancer – Cancer Research, 2009

  9.  Compartment Syndrome as Presentation of Chronic Myelogenous Leukemia – J Gen Intern Med, 2010

  10.  Use of Insulin and its Effect on Survival in NSCLC – J Clin Oncol, 2009

Conclusion:

Dr. Amr AlHanbali demonstrates a stellar blend of clinical expertise, research productivity, academic mentorship, and leadership in hematology and oncology. His research contributions have practical implications in areas such as multiple myeloma, leukemia, transplant immunology, and chemotherapy safety.

He is highly deserving of recognition and stands out as a top contender for a Best Researcher Award, particularly in the categories of clinical research excellence, translational hematology, and medical education integration with research.

Ying Ren | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Mrs. Ying Ren | Stem Cell Research | Best Researcher Award

Mrs. Ying Ren , Xuzhou Medical University , China

Ying Ren, a 32-year-old researcher from Xuzhou, Jiangsu province, China, is an accomplished scholar specializing in biomedical engineering. After completing her PhD at Peking Union Medical College, Tsinghua University Health Science Center (2015-2021), she is currently serving as a lecturer at the School of Stomatology, Xuzhou Medical University. Ren’s research journey is centered on bone marrow stem cells and their differentiation into odontogenic and osteogenic lineages. She is also deeply involved in exploring the synthesis and design of natural bioactive hydrogels aimed at enhancing bone tissue regeneration. Throughout her career, Ren has contributed to numerous impactful publications, demonstrating her expertise in the development of materials and techniques that support regenerative medicine.

Publication Profile: 

Scopus

Strengths for the Award:

Ying Ren’s academic and research profile positions her as a leading candidate for the Best Researcher Award in the field of biomedical engineering and tissue regeneration. Her research is highly innovative, with a focus on bone marrow stem cell differentiation and bioactive hydrogels designed to promote bone tissue regeneration. Ren’s ability to integrate molecular biology with material science is a key strength that is reflected in her numerous impactful publications. Her work in hydrogel design and stem cell culture systems stands out as cutting-edge, with clear implications for regenerative medicine and tissue engineering. The significant impact of her research is shown by her consistent publication in top-tier journals such as ACS Applied Bio Materials, Journal of Biomedical Nanotechnology, and Biomaterials. Moreover, her academic leadership as a lecturer at Xuzhou Medical University further demonstrates her capacity to contribute to both the scientific community and the education of future researchers.

Areas for Improvement:

While Ren’s research is highly promising, there is potential for expanding her focus to explore the clinical applications and translational aspects of her work more thoroughly. Moving beyond the lab and advancing her bioactive hydrogels and stem cell differentiation strategies toward clinical trials could greatly enhance the practical impact of her research. Additionally, while Ren has been successful in her publications, future collaborations with interdisciplinary researchers in the fields of clinical medicine and industry could help further elevate her work to new applications in regenerative therapies.

Education:

Ying Ren’s academic journey began with her Bachelor’s degree in Pharmacy from Tianjin Medical University (2011-2015), where she laid the foundation for her deep interest in biomedical sciences. She went on to pursue her PhD in Biomedical Engineering at Peking Union Medical College, Tsinghua University Health Science Center (2015-2021). Here, she focused on stem cell biology, particularly the odontogenic and osteogenic differentiation of bone marrow stem cells. Ren’s advanced research training equipped her with a solid understanding of the molecular mechanisms involved in tissue regeneration and the bioengineering of materials to promote this process. Her education has allowed her to merge the fields of pharmacy, biomedical engineering, and material science, which has been pivotal in shaping her current research direction. She has since become a well-respected academic, contributing valuable knowledge to the field of tissue engineering and regenerative medicine.

Experience:

Since August 2021, Ying Ren has been serving as a lecturer at the School of Stomatology, Xuzhou Medical University, where she continues to advance her research and teach the next generation of biomedical engineers. Before her current position, Ren had extensive academic exposure during her PhD, where she collaborated on various multidisciplinary projects that bridged the fields of stem cell biology, bioengineering, and material science. In her role as a lecturer, she not only teaches but also leads cutting-edge research in the development of natural bioactive hydrogels and their application in bone tissue regeneration. Her work is highly regarded in the academic community, and she has published several influential papers in top-tier journals. Ren’s research continues to focus on improving therapeutic outcomes for regenerative medicine, particularly through her exploration of bioactive materials designed for bone regeneration and cartilage repair.

Research Focus:

Ying Ren’s research is primarily focused on the differentiation of bone marrow-derived stem cells into odontogenic and osteogenic lineages, a key area for advancing bone tissue regeneration. She investigates the molecular and biomechanical mechanisms that regulate stem cell behavior and tissue formation. Her work emphasizes the design and synthesis of bioactive hydrogels, including collagen mimetic peptides and hyaluronic acid derivatives, to create environments that promote stem cell differentiation and tissue healing. In particular, Ren is dedicated to developing hydrogels with adjustable mechanical properties, facilitating controlled cell growth and tissue regeneration. Her innovative approach holds great promise for enhancing the repair of bone and cartilage defects. Moreover, Ren is exploring how different hydrogel stiffness and molecular structures influence stem cell fate, aiming to optimize these materials for clinical applications in regenerative medicine. Her research bridges fundamental biology with advanced materials science to address unmet medical needs in tissue engineering.

Publications Top Notes:

  1. Hyaluronic acid hydrogel with adjustable stiffness for mesenchymal stem cell 3D culture 🧬🦠, ACS Applied Bio Materials, 2021
  2. A gelatin-hyaluronic acid double cross-linked hydrogel for regulating the growth and dual dimensional cartilage differentiation of bone marrow mesenchymal stem cells 🧫💡, Journal of Biomedical Nanotechnology, 2021
  3. Locally delivered modified citrus pectin-a galectin-3 inhibitor shows expected anti-inflammatory and unexpected regeneration-promoting effects on repair of articular cartilage defect 🍊🦵, Biomaterials, 2022
  4. The effects of stiffness on the specificity and avidity of antibody-coated microcapsules with target cells are strongly shape dependent 🧪🔬, Colloids and Surfaces B: Biointerfaces, 2024
  5. A collagen mimetic peptide-modified hyaluronic acid hydrogel system with enzymatically mediated degradation for mesenchymal stem cell differentiation 🧬🛠, Materials Science & Engineering C, 2020

Conclusion:

Ying Ren’s innovative contributions to the fields of stem cell biology, bioengineering, and regenerative medicine make her a highly deserving candidate for the Best Researcher Award. Her work has the potential to advance medical treatments for bone and cartilage regeneration, a critical area in tissue engineering. With her proven track record, expertise, and dedication, Ren is well-positioned to continue leading groundbreaking research and making significant strides in the medical field.

Chunli Ma | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Ms. Chunli Ma | Stem Cell Research | Best Researcher Award

Ms. Chunli Ma  , Shandong Provincial Hospital Affiliated to Shandong First Medical University , China

Chunli Ma is a Master’s student at Shandong Provincial Hospital Affiliated with Shandong First Medical University in China. With a strong background in Optometry and Vision Science, Ma has expanded into Ophthalmology for her graduate studies. She possesses a deep understanding of ocular disorders and the corresponding diagnostic and treatment protocols. She is passionate about cellular and molecular experimentation, specializing in animal models for scientific research. Her expertise extends to experimental techniques that offer innovative solutions for eye injury and healing. Chunli’s work aims to improve corneal repair, reduce scarring, and enhance treatment outcomes for ocular diseases through advanced therapeutic approaches, including stem cell therapy and specialized eye drops.

Publication Profile:

Orcid

Strengths for the Award:

Chunli Ma is a promising researcher with a strong foundation in both clinical ophthalmology and experimental techniques. Her academic background in Optometry and Vision Science, along with her specialized focus on Ophthalmology, positions her as an emerging leader in the field. Ma’s contributions to the understanding and treatment of corneal injuries, particularly her work on exosomes derived from adipose mesenchymal stem cells and antibacterial eyedrops, have significant therapeutic potential. The formulation of exosomes into eyedrops to aid in rapid corneal healing and prevent scarring, along with the development of multifunctional eyedrops for treating bacterial keratitis, showcases her innovative approach to solving complex clinical challenges. Her ability to translate laboratory research into potential clinical applications is commendable. Moreover, her publications in well-regarded journals and ongoing involvement in impactful research add to her eligibility for the Best Researcher Award.

Areas for Improvement:

While Chunli Ma’s work demonstrates great potential, there are areas where she could continue to develop. Expanding her research to a broader range of ocular conditions beyond corneal injury and keratitis could make her work even more influential across various ophthalmic fields. Additionally, seeking more collaborations with interdisciplinary teams, such as those focusing on the genetic and molecular mechanisms of ocular diseases, could provide deeper insights and enhance her ability to tackle more complex issues. Although she has made valuable contributions to scientific publications, continuing to increase the number and impact of her published papers, especially in top-tier journals, will further solidify her reputation in the scientific community. Gaining experience in patent applications and commercialization of her research could also help bridge the gap between laboratory findings and real-world clinical application.

Education:

Chunli Ma completed her undergraduate degree in Optometry and Vision Science, where she gained foundational knowledge in ocular health and vision correction. Building on this, she pursued a Master’s degree in Ophthalmology, which allowed her to specialize in clinical and experimental ophthalmic research. Her academic journey includes hands-on research in cell biology, molecular techniques, and experimental models to address common ocular disorders, particularly in corneal injury repair. Chunli’s academic training has not only refined her diagnostic skills but also equipped her with cutting-edge knowledge in treatment and therapeutic strategies. Her graduate work bridges practical clinical care with advanced research, focusing on cellular regeneration, stem cell treatments, and tissue healing in the eye. This robust academic background underpins her ongoing commitment to advancing ophthalmic medicine through innovative scientific inquiry and applied research in the field of corneal injury and wound healing.

Experience:

Chunli Ma’s academic journey has been bolstered by hands-on experience in both clinical ophthalmology and cellular research. Her work in experimental ophthalmology has focused on the use of adipose mesenchymal stem cells for corneal repair, creating new methodologies for promoting healing and reducing scarring. She has demonstrated expertise in animal model management and experimentation, gaining insights into complex biological processes affecting eye injuries. Ma has contributed to the development of novel treatments, including multifunctional eye drops for both bacterial keratitis and corneal trauma. Her research findings have important clinical implications, directly informing therapeutic strategies for ocular health. Additionally, Ma’s experience includes publishing scientific articles, with a growing portfolio in well-regarded journals. This combination of clinical knowledge, experimental research, and hands-on technique has allowed her to make valuable contributions to ophthalmic science, particularly in terms of innovative solutions for corneal injury and healing.

Research Focus:

Chunli Ma’s research focus is centered on the mechanistic modulation of corneal injury and wound healing. She investigates the potential of stem cell-derived exosomes in promoting the regeneration of corneal tissues, with a particular interest in their role in reducing scarring after trauma. Her work delves into advanced therapeutic applications, such as multifunctional eye drops containing composite antibacterial and healing properties for the treatment of Pseudomonas aeruginosa keratitis. By targeting the underlying molecular and cellular mechanisms of corneal repair, Ma aims to offer innovative solutions for treating corneal injuries and infections. Her research also explores the impact of wound size and location on the prognosis of penetrating ocular injuries, offering a more nuanced approach to patient care. Chunli’s focus on the development of cutting-edge materials and therapies for ophthalmic applications promises significant advances in clinical practice, particularly for patients with challenging corneal conditions.

Publications Top Notes:

  1. Exosomes derived from adipose mesenchymal stem cells promote corneal injury repair and inhibit the formation of scars by anti-apoptosis 📑🧬
  2. Wound size and location affect the prognosis of penetrating ocular injury 👁️‍🗨️🩹
  3. Potential role of ARG1 c.57G > A variant in Argininemia 🔬🧬

Conclusion:

Chunli Ma’s research reflects an excellent blend of clinical expertise and innovative scientific inquiry. Her work has already made notable contributions to improving the treatment of ocular injuries, particularly in corneal healing and bacterial keratitis. With a clear focus on translational research, she has demonstrated the potential for significant advancements in ophthalmic treatments. Given her ongoing dedication to advancing ophthalmology through novel therapeutic approaches, Chunli Ma is undoubtedly a strong candidate for the Best Researcher Award. With continued growth in her research, collaboration efforts, and scholarly output, she has the potential to make even greater strides in the field of ophthalmology and regenerative medicine.